The portfolio maintains a cost advantage over competitors, priced within the second-cheapest fee quintile among peers.
Baillie Gifford Health Inn Eq Instl BGHBX
- NAV / 1-Day Return 5.98 / 0.00
- Total Assets 6.8 Mil
-
Adj. Expense Ratio
- Expense Ratio 0.750%
- Distribution Fee Level Below Average
- Share Class Type Institutional
- Category Health
- Investment Style Mid Growth
- Min. Initial Investment 0
- Status Open
- TTM Yield 0.00
- Turnover 23%
USD | NAV as of Oct 02, 2024 | 1-Day Return as of Oct 02, 2024, 10:12 PM GMT+0
Morningstar’s Analysis BGHBX
Will BGHBX outperform in future?
Get our overall rating based on a fundamental assessment of the pillars below.
People Pillar
Parent Pillar
- Current Portfolio Date
- Equity Holdings —
- Bond Holdings —
- Other Holdings —
- % Assets in Top 10 Holdings 53.1
Top 10 Holdings
|
% Portfolio Weight
|
Market Value USD
|
Sector
|
---|---|---|---|
Alnylam Pharmaceuticals Inc | 7.05 | 1.1 Mil | Healthcare |
Moderna Inc | 6.93 | 1.1 Mil | Healthcare |
argenx SE | 6.40 | 1.0 Mil | Healthcare |
Alk-Abello A/S Class B | 5.52 | 883,369 | Healthcare |
Ambu A/S Class B | 5.23 | 837,909 | Healthcare |
DexCom Inc | 4.88 | 781,755 | Healthcare |
Edwards Lifesciences Corp | 4.82 | 771,474 | Healthcare |
Genmab A/S | 4.77 | 763,384 | Healthcare |
Ionis Pharmaceuticals Inc | 3.95 | 632,877 | Healthcare |
Insulet Corp | 3.53 | 565,444 | Healthcare |